---
title: The Influence of Immunodeficiency, Disease Features and Patient Characteristics
  on Survival in Plasmablastic Lymphoma
date: '2023-10-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37832030/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20231014180801&v=2.17.9.post6+86293ac
source: Blood
description: Plasmablastic lymphoma (PBL) is a rare and aggressive non-Hodgkin lymphoma
  associated with immunodeficiency, characterized by uncertain treatment approaches
  and an unfavourable prognosis. We conducted a multicenter, international, retrospective
  cohort study, aiming to characterize the clinical features, risk factors, and outcomes
  of patients with PBL. Data were collected from 22 institutions across four countries
  regarding patients diagnosed with PBL between 1 January 1999 and 31 December ...
disable_comments: true
---
Plasmablastic lymphoma (PBL) is a rare and aggressive non-Hodgkin lymphoma associated with immunodeficiency, characterized by uncertain treatment approaches and an unfavourable prognosis. We conducted a multicenter, international, retrospective cohort study, aiming to characterize the clinical features, risk factors, and outcomes of patients with PBL. Data were collected from 22 institutions across four countries regarding patients diagnosed with PBL between 1 January 1999 and 31 December ...